My understanding is only what the MARINE trial predicted is under consideration. Were those results obvious?
Even if that is so the generics shouldn't be allowed to sell under the guise of the MARINE label, the Reduce-It patents should be retroactive to the earlier indication.
Also, is the hiring of additional lawyers by Amarin an indication that we're going to trial???